Mobile Health Exercise Regimen for Heart Valve Disease
(HOMERUNHITTER Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment Home-Based Cardiac Rehabilitation for heart valve disease?
Is home-based cardiac rehabilitation safe for humans?
How is the Home-Based Cardiac Rehabilitation treatment different from other treatments for heart valve disease?
Home-Based Cardiac Rehabilitation (HBCR) is unique because it allows patients to perform their cardiac rehabilitation exercises at home, often using smartphone apps for guidance and monitoring, which can improve exercise capacity and reduce cardiac risks without needing frequent hospital visits.13789
What is the purpose of this trial?
The vast majority of cardiac rehabilitation eligible individuals do not participate in center based cardiac rehabilitation (CBCR). While steps to encourage participation in CBCR are important, many individuals will still not participate for a variety of reasons. This randomized controlled trial is evaluating a home-based cardiac rehabilitation (HBCR) intervention delivered using a custom app and digital tools in patients undergoing transcatheter heart valve interventions (THVIs). After a brief roll-in period, participants not intending to participate in CBCR are randomized to one of three groups: (1) control, (2) HBCR mobile health intervention with hands-off delivery, and (3) HBCR mobile health intervention with interactive delivery. Participants in the intervention groups (hands-off/interactive delivery) will also be randomized to continue the intervention for 12 weeks or 24 weeks. The intervention targets key health behaviors and includes traditional cardiac rehabilitation components. The study will assess the effect of the intervention on clinical events, physical activity, quality of life, and other outcomes. Those who intend to participate in CBCR will be followed in a registry.
Research Team
Brian R. Lindman, MD
Principal Investigator
Vanderbilt University Medical Center
Eligibility Criteria
This trial is for heart valve disease patients who've had a transcatheter heart valve intervention via the leg. They must be able to use an activity tracker, not planning on joining center-based rehab, and capable of using digital tools without physical or mental limitations that would interfere.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Roll-in
Brief roll-in period before randomization
Treatment
Participants receive home-based cardiac rehabilitation using a mobile app, randomized to either hands-off or interactive delivery for 12 or 24 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Home-Based Cardiac Rehabilitation
Home-Based Cardiac Rehabilitation is already approved in European Union, United States, Canada for the following indications:
- Coronary artery disease
- Heart failure
- Post-myocardial infarction rehabilitation
- Post-percutaneous coronary intervention rehabilitation
- Post-coronary artery bypass grafting rehabilitation
- Coronary artery disease
- Heart failure
- Post-myocardial infarction rehabilitation
- Post-percutaneous coronary intervention rehabilitation
- Post-coronary artery bypass grafting rehabilitation
- Coronary artery disease
- Heart failure
- Post-myocardial infarction rehabilitation
- Post-percutaneous coronary intervention rehabilitation
- Post-coronary artery bypass grafting rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
Wake Forest University Health Sciences
Collaborator
Morristown Medical Center
Collaborator
Piedmont Healthcare
Collaborator
Inova Fairfax Hospital
Collaborator
Chattanooga-Hamilton County Hospital Authority
Collaborator
Medical University of South Carolina
Collaborator
Duke Clinical Research Institute
Collaborator
University of Michigan
Collaborator
Pinnacle Health Cardiovascular Institute
Collaborator